Table 3.
Treatment and outcomes
| Isolated pleurisy group (N = 51) | Pleuro-pulmonary group (N = 154) | p value | |
|---|---|---|---|
| Anti-tuberculous treatment | 46 (90%) | 130 (84%) | 0.305 |
| Tube thoracostomy or decortication | 4 (8%) | 24 (16%) | 0.163 |
| Days-to-treatment | 6 [26.8] | 9 [15.6] | 0.367 |
| Within 2 weeks | 35 (69%) | 86 (56%) | 0.264 |
| More than 2 weeks | 11 (21%) | 44 (28%) | |
| Not treated | 5 (10%) | 24 (16%) | |
| Residual pleura thickening* | |||
| ≥ 10 mm | 10 (29%) | 24 (35%) | 0.542 |
| < 10 mm | 25 (71%) | 45 (65%) | |
| In-hospital mortality rate | 2 (4%) | 37 (24%) | 0.001 |
| Length of hospital stay: days | 22 [20.8] | 33 [27.9] | 0.003 |
Data are no. (%) or mean [SD]
* After six months of anti-tuberculous treatment, only 36 patients in the isolated pleurisy group and 72 in the pleuro-pulmonary group were still being followed in our hospital.